Barbara Burtness

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 28 papers. Top paper: “Head and neck squamous cell carcinoma”.

Head and neck squamous cell carcinoma

Nature Reviews Disease Primers(2020)10.1038/s41572-020-00224-3

N/A

10.9DataRank · unranked

3996 citations

Barbara Burtness, C. René Leemans, Vivian Wai Yan Lui, Julie E. Bauman, Jennifer R. Grandis +1 more

Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6500

N/A

0.694DataRank · unranked

101 citations

Yael Flamand, Gregory S. Weinstein, Shuli Li, Harry Quon, Ranee Mehra +15 more

Association of T P53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4316

N/A

0.678DataRank · unranked

91 citations

Yasmine Baca, Ilya G. Serebriiskii, Émmanuelle Nicolas, Mitchell I. Parker, Theodore T. Nguyen +8 more

Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trial

The Lancet Digital Health(2023)10.1016/s2589-7500(23)00046-8

N/A

0.648DataRank · unranked

74 citations

Jirapat Likitlersuang, Dennis Bontempi, Zezhong Ye, Sanjay Aneja, Richard L. Bakst +16 more

Kidney-Targeted Renalase Agonist Prevents Cisplatin-Induced Chronic Kidney Disease by Inhibiting Regulated Necrosis and Inflammation

Journal of the American Society of Nephrology(2021)10.1681/asn.2021040439

N/A

0.628DataRank · unranked

65 citations

Leyuan Xu, Heino Velázquez, Tian-Min Chen, Ryan M. Williams, Daniel A. Heller +4 more

A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311

Oral Oncology(2020)10.1016/j.oraloncology.2020.104797

N/A

0.574DataRank · unranked

45 citations

Yael Flamand, F. Christopher Holsinger, Gregory S. Weinstein, Harry Quon, Ranee Mehra +28 more

An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers

Oral Oncology(2024)10.1016/j.oraloncology.2024.106750

N/A

0.479DataRank · unranked

9 citations

Myrto Moutafi, Yalai Bai, Thazin Nwe Aung, Sneha Burela, Matthew Liu +9 more

Outcomes by tobacco history in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6077

N/A

0.385DataRank · unranked

12 citations

Yael Flamand, Harry Quon, Joaquín J. García, Gregory S. Weinstein, Umamaheswar Duvvuri +12 more

Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma (HNSCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6015

N/A

0.312DataRank · unranked

7 citations

Nabil F. Saba, Denise J. Roe, Jessica R. Bauman, John M. Kaczmar, Aarti Bhatia +14 more

Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-4085

N/A

0.292DataRank · unranked

6 citations

Yael Flamand, Derrick T. Lin, Christine H. Chung, Mark W. McDonald, Stella Flampouri +20 more

Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial

The Oncologist(2023)10.1093/oncolo/oyad096

N/A

0.276DataRank · unranked

5 citations

Paul Catalano, Steven J. Cohen, Barbara Burtness, Edith Mitchell, Efrat Dotan +7 more

Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6036

N/A

0.165DataRank · unranked

2 citations

Yael Flamand, Harry Quon, Gregory S. Weinstein, Ranee Mehra, Joaquín J. García +11 more

A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305

European Journal of Cancer(2023)10.1016/j.ejca.2023.113509

N/A

0DataRank · unranked

1 citations

Yael Flamand, P. Savvides, Jennifer M. Johnson, Ioannis Vathiotis, Marshall Levine +4 more

Data from Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer

(2023)10.1158/1078-0432.c.6532500

N/A

0DataRank · unranked

0 citations

Yasmine Baca, Ilya G. Serebriiskii, Émmanuelle Nicolas, Mitchell I. Parker, Theodore T. Nguyen +8 more

De-Escalated Therapy and Early Treatment of Recurrences in HPV-Associated Head and Neck Cancer: The Potential for Biomarkers to Revolutionize Personalized Therapy

Viruses(2024)10.3390/v16040536

N/A

0DataRank · unranked

10 citations

Travis P. Schrank, Barbara Burtness, Natalia Issaeva, Wendell G. Yarbrough

NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer

UNC Libraries(2024)10.17615/672t-j772

N/A

0DataRank · unranked

0 citations

Travis P. Schrank, Damir Alzhanov, Xiaowei Wang, Wendell G. Yarbrough, Albert S. Baldwin +5 more

In vivo assessment of differential toxicity of cancer treatment drugs in Fanconi’s Anemia

10.1101/2025.11.21.689800

N/A

0DataRank · unranked

0 citations

Sebastian Cruz-Gomez, Allison MacMillan, Alexander Peters, Barbara Burtness, Markus Grompe +1 more

Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck Cancer

Cancers(2020)10.3390/cancers12020306

N/A

0DataRank · unranked

23 citations

Margret B. Einarson, John M. Bennett, Anna S. Nikonova, Mohamed Elmekawy, Yan Zhou +4 more

ECOG-ACRIN 2399: analysis of patient related outcomes after Chemoradiation for locally advanced head and neck Cancer

Cancers of the Head & Neck(2020)10.1186/s41199-020-00059-1

N/A

0DataRank · unranked

7 citations

Mary S. Dietrich, Shuli Li, Sheila H. Ridner, Arlene A. Forastiere, Barbara Burtness +3 more

ECOG-ACRIN 2399: Analysis of Patient Related Outcomes After Chemoradiation for Locally Advanced Head and Neck Cancer

Research Square(2020)10.21203/rs.3.rs-33337/v1

N/A

0DataRank · unranked

0 citations

Mary S. Dietrich, Shuli Li, Sheila H. Ridner, Arlene A. Forastiere, Barbara Burtness +3 more

STING enhances cell death through regulation of reactive oxygen species and DNA damage

Nature Communications(2021)10.1038/s41467-021-22572-8

N/A

0DataRank · unranked

212 citations

Marta Baro, Tyler MacNeil, Chatchai Phoomak, Thazin Nwe Aung, Wei Cui +8 more

Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study

Cancer(2021)10.1002/cncr.33641

N/A

0DataRank · unranked

66 citations

Jonathan J. Beitler, Gang Peng, Morgan E. Levine, Karen N. Conneely, Hongyu Zhao +11 more

ECOG-ACRIN 2399: Analysis of Patient Related Outcomes after Chemoradiation for Locally Advanced Head and Neck Cancer

Research Square(2021)10.21203/rs.3.rs-33337/v2

N/A

0DataRank · unranked

0 citations

Mary S. Dietrich, Shuli Li, Sheila H. Ridner, Arlene A. Forastiere, Barbara Burtness +3 more

NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer

Oncotarget(2022)10.18632/oncotarget.28232

N/A

0DataRank · unranked

18 citations

Andrew C. Prince, Tejas Sathe, Xiaowei Wang, Xinyi Liu, Damir Alzhanov +5 more

A phase II/III trial of chemotherapy plus cetuximab versus chemotherapy plus bevacizumab versus atezolizumab plus bevacizumab following progression on immune checkpoint inhibition in recurrent/metastatic head and neck cancers: ECOG-ACRIN EA3202.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps6098

N/A

0DataRank · unranked

5 citations

Yael Flamand, Jennifer M. Johnson, Jeffrey J. Ishizuka, Fenghai Duan, Mei Tang +4 more

A new prognostic model in patients with recurrent or metastatic head and neck cancer treated with chemotherapy: An analysis of ECOG-ACRIN E1305.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6026

N/A

0DataRank · unranked

0 citations

Yael Flamand, P. Savvides, Jennifer M. Johnson, Shuli Li, Arlene A. Forastiere +2 more

The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad121

N/A

0DataRank · unranked

9 citations

Barbara Burtness, May Cho, Jaydira Del Rivero, Deborah B. Doroshow, Kathryn Hitchcock +12 more

Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review

Viruses(2023)10.3390/v15122320

N/A

0DataRank · unranked

4 citations

Wei Wang, Niki Gavrielatou, Leslie Christensen, Paul F. Lambert, Paul M. Harari +5 more